|
ARRDC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49169999996701E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26720000004354E-06 |
| Normal-vs-Stage2 |
4.055500E-03 |
| Normal-vs-Stage3 |
1.410470E-02 |
| Normal-vs-Stage4 |
7.201000E-01 |
| Stage1-vs-Stage2 |
4.108200E-01 |
| Stage1-vs-Stage3 |
9.316300E-02 |
| Stage1-vs-Stage4 |
5.429500E-02 |
| Stage2-vs-Stage3 |
5.512400E-01 |
| Stage2-vs-Stage4 |
1.049980E-01 |
| Stage3-vs-Stage4 |
1.635410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.75839999519923E-08 |
| Normal-vs-AfricanAmerican |
1.028300E-02 |
| Normal-vs-Asian |
1.812180E-01 |
| Caucasian-vs-AfricanAmerican |
1.755980E-01 |
| Caucasian-vs-Asian |
3.431800E-01 |
| AfricanAmerican-vs-Asian |
8.479400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.27760000251587E-08 |
| Normal-vs-Female |
7.162400E-03 |
| Male-vs-Female |
5.694200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.680300E-03 |
| Normal-vs-Extreme_Weight |
1.47139999995272E-06 |
| Normal-vs-Obese |
6.169800E-04 |
| Normal-vs-Extreme_Obese |
1.596620E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.942000E-01 |
| Normal_Weight-vs-Obese |
9.210600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.428400E-02 |
| Extreme_Weight-vs-Obese |
9.599600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.423800E-01 |
| Obese-vs-Extreme_Obese |
2.054500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.354960E-01 |
| Normal-vs-Age(41-60Yrs) |
4.982000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.15820000035072E-07 |
| Normal-vs-Age(81-100Yrs) |
7.49640000075047E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.532000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.710400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.091780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.126400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.753400E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.964000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59990000003774E-06 |
| Normal-VS-Type2 PRCC |
1.7758999999451E-06 |
| Normal-VS-KIRP CIMP |
8.740200E-02 |
| Normal-VS-Unclassified PRCC |
2.617300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.210200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.359500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.356400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.839800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.514000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.758500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88867999999509E-05 |
| Normal-vs-N1 |
2.208800E-01 |
| Normal-vs-N2 |
7.438000E-01 |
| N0-vs-N1 |
1.804120E-02 |
| N0-vs-N2 |
3.360800E-01 |
| N1-vs-N2 |
5.637600E-01 |
|
|
